The endothelial Dll4–muscular Notch2 axis regulates skeletal muscle mass

Shin Fujimaki; Tomohiro Matsumoto; Masashi Muramatsu; Hiroshi Nagahisa; Naoki Horii; Daiki Seko; Shinya Masuda; Xuerui Wang; Yoko Asakura; Yukie Takahashi; Yuta Miyamoto; Shingo Usuki; Kei ichiro Yasunaga; Yasutomi Kamei; Ryuichi Nishinakamura; Takashi Minami; Takaichi Fukuda; Atsushi Asakura; Yusuke Ono

doi:10.1038/s42255-022-00533-9

The endothelial Dll4–muscular Notch2 axis regulates skeletal muscle mass

Shin Fujimaki
, Tomohiro Matsumoto
, Masashi Muramatsu
, Hiroshi Nagahisa
, Naoki Horii
, Daiki Seko
, Shinya Masuda
, Xuerui Wang
, Yoko Asakura
, Yukie Takahashi
, Yuta Miyamoto
, Shingo Usuki
, Kei ichiro Yasunaga
, Yasutomi Kamei
, Ryuichi Nishinakamura
, Takashi Minami
, Takaichi Fukuda
, Atsushi Asakura
, Yusuke Ono

Research output: Contribution to journal › Article › peer-review

49 Scopus citations

Abstract

Adult skeletal muscle is a highly plastic tissue that readily reduces or gains its mass in response to mechanical and metabolic stimulation; however, the upstream mechanisms that control muscle mass remain unclear. Notch signalling is highly conserved, and regulates many cellular events, including proliferation and differentiation of various types of tissue stem cell via cell–cell contact. Here we reveal that multinucleated myofibres express Notch2, which plays a crucial role in disuse- or diabetes-induced muscle atrophy. Mechanistically, in both atrophic conditions, the microvascular endothelium upregulates and releases the Notch ligand, Dll4, which then activates muscular Notch2 without direct cell–cell contact. Inhibition of the Dll4–Notch2 axis substantively prevents these muscle atrophy and promotes mechanical overloading-induced muscle hypertrophy in mice. Our results illuminate a tissue-specific function of the endothelium in controlling tissue plasticity and highlight the endothelial Dll4–muscular Notch2 axis as a central upstream mechanism that regulates catabolic signals from mechanical and metabolic stimulation, providing a therapeutic target for muscle-wasting diseases.

Original language	English (US)
Pages (from-to)	180-189
Number of pages	10
Journal	Nature Metabolism
Volume	4
Issue number	2
DOIs	https://doi.org/10.1038/s42255-022-00533-9
State	Published - Feb 2022

Bibliographical note

Funding Information:
We thank R. Fujita, S. Ogawa, Y. Tsuchiya, K. Yoshioka, Y. Kitajima, D. T. Shima, Y. Kubota and N. Suzuki for sharing materials and technical assistance. We also thank S. Burden for providing Mlc1f-Cre mice; I. Imayoshi and R. Kageyama for providing Hes1-flox mice and T. Honjo for providing RBPJ-flox mice. The Pax7 and MF20 antibodies, developed by A. Kawakami and D.A. Fischman, respectively, were obtained from the Developmental Studies Hybridoma Bank developed under the auspices of the NICHD and maintained by the University of Iowa. This work was supported by the FOREST program of the Japan Science and Technology Agency (JST, grant no. JPMJFR205C to Y.O.), the Japan Agency for Medical Research and Development (AMED, grant no. JP19bm0704036 to Y.O.) and Grants-in-Aid for Scientific Research KAKENHI (grant nos. 25882024 to S.M.; 15H05368, 18H03193 and 20K21763 to Y.O.; 20K19641 to S.F. and 20J01669 to T.Ma.). This work was also supported, in part, by the Center for Metabolic Regulation of Healthy Aging (to Y.O. and S.F.), the Takeda Science Foundation (to Y.O. and S.F.), the Naito Foundation (to Y.O.), the Uehara Memorial Foundation (to S.F.), NIH R21 (grant no. AR078400 to A.A.) and Regenerative Medicine Minnesota (grant no. 092319 TR010 to A.A.). T.Ma., H.N. and N.H. were funded by a JSPS Research Fellowship.

Funding Information:
We thank R. Fujita, S. Ogawa, Y. Tsuchiya, K. Yoshioka, Y. Kitajima, D. T. Shima, Y. Kubota and N. Suzuki for sharing materials and technical assistance. We also thank S. Burden for providing Mlc1f-Cre mice; I. Imayoshi and R. Kageyama for providing Hes1-flox mice and T. Honjo for providing RBPJ-flox mice. The Pax7 and MF20 antibodies, developed by A. Kawakami and D.A. Fischman, respectively, were obtained from the Developmental Studies Hybridoma Bank developed under the auspices of the NICHD and maintained by the University of Iowa. This work was supported by the FOREST program of the Japan Science and Technology Agency (JST, grant no. JPMJFR205C to Y.O.), the Japan Agency for Medical Research and Development (AMED, grant no. JP19bm0704036 to Y.O.) and Grants-in-Aid for Scientific Research KAKENHI (grant nos. 25882024 to S.M.; 15H05368, 18H03193 and 20K21763 to Y.O.; 20K19641 to S.F. and 20J01669 to T.Ma.). This work was also supported, in part, by the Center for Metabolic Regulation of Healthy Aging (to Y.O. and S.F.), the Takeda Science Foundation (to Y.O. and S.F.), the Naito Foundation (to Y.O.), the Uehara Memorial Foundation (to S.F.), NIH R21 (grant no. AR078400 to A.A.) and Regenerative Medicine Minnesota (grant no. 092319 TR010 to A.A.). T.Ma., H.N. and N.H. were funded by a JSPS Research Fellowship.

Publisher Copyright:
© 2022, The Author(s), under exclusive licence to Springer Nature Limited.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Publisher link

10.1038/s42255-022-00533-9

Find It

Find It at U of M Libraries

Cite this

Fujimaki, S., Matsumoto, T., Muramatsu, M., Nagahisa, H., Horii, N., Seko, D., Masuda, S., Wang, X., Asakura, Y., Takahashi, Y., Miyamoto, Y., Usuki, S., Yasunaga, K. I., Kamei, Y., Nishinakamura, R., Minami, T., Fukuda, T., Asakura, A., & Ono, Y. (2022). The endothelial Dll4–muscular Notch2 axis regulates skeletal muscle mass. Nature Metabolism, 4(2), 180-189. https://doi.org/10.1038/s42255-022-00533-9

Fujimaki, S, Matsumoto, T, Muramatsu, M, Nagahisa, H, Horii, N, Seko, D, Masuda, S, Wang, X, Asakura, Y, Takahashi, Y, Miyamoto, Y, Usuki, S, Yasunaga, KI, Kamei, Y, Nishinakamura, R, Minami, T, Fukuda, T, Asakura, A & Ono, Y 2022, 'The endothelial Dll4–muscular Notch2 axis regulates skeletal muscle mass', Nature Metabolism, vol. 4, no. 2, pp. 180-189. https://doi.org/10.1038/s42255-022-00533-9

@article{f5e7050e50674fa4a2315ad6670a5bfb,

title = "The endothelial Dll4{\textendash}muscular Notch2 axis regulates skeletal muscle mass",

abstract = "Adult skeletal muscle is a highly plastic tissue that readily reduces or gains its mass in response to mechanical and metabolic stimulation; however, the upstream mechanisms that control muscle mass remain unclear. Notch signalling is highly conserved, and regulates many cellular events, including proliferation and differentiation of various types of tissue stem cell via cell{\textendash}cell contact. Here we reveal that multinucleated myofibres express Notch2, which plays a crucial role in disuse- or diabetes-induced muscle atrophy. Mechanistically, in both atrophic conditions, the microvascular endothelium upregulates and releases the Notch ligand, Dll4, which then activates muscular Notch2 without direct cell{\textendash}cell contact. Inhibition of the Dll4{\textendash}Notch2 axis substantively prevents these muscle atrophy and promotes mechanical overloading-induced muscle hypertrophy in mice. Our results illuminate a tissue-specific function of the endothelium in controlling tissue plasticity and highlight the endothelial Dll4{\textendash}muscular Notch2 axis as a central upstream mechanism that regulates catabolic signals from mechanical and metabolic stimulation, providing a therapeutic target for muscle-wasting diseases.",

author = "Shin Fujimaki and Tomohiro Matsumoto and Masashi Muramatsu and Hiroshi Nagahisa and Naoki Horii and Daiki Seko and Shinya Masuda and Xuerui Wang and Yoko Asakura and Yukie Takahashi and Yuta Miyamoto and Shingo Usuki and Yasunaga, \{Kei ichiro\} and Yasutomi Kamei and Ryuichi Nishinakamura and Takashi Minami and Takaichi Fukuda and Atsushi Asakura and Yusuke Ono",

note = "Funding Information: We thank R. Fujita, S. Ogawa, Y. Tsuchiya, K. Yoshioka, Y. Kitajima, D. T. Shima, Y. Kubota and N. Suzuki for sharing materials and technical assistance. We also thank S. Burden for providing Mlc1f-Cre mice; I. Imayoshi and R. Kageyama for providing Hes1-flox mice and T. Honjo for providing RBPJ-flox mice. The Pax7 and MF20 antibodies, developed by A. Kawakami and D.A. Fischman, respectively, were obtained from the Developmental Studies Hybridoma Bank developed under the auspices of the NICHD and maintained by the University of Iowa. This work was supported by the FOREST program of the Japan Science and Technology Agency (JST, grant no. JPMJFR205C to Y.O.), the Japan Agency for Medical Research and Development (AMED, grant no. JP19bm0704036 to Y.O.) and Grants-in-Aid for Scientific Research KAKENHI (grant nos. 25882024 to S.M.; 15H05368, 18H03193 and 20K21763 to Y.O.; 20K19641 to S.F. and 20J01669 to T.Ma.). This work was also supported, in part, by the Center for Metabolic Regulation of Healthy Aging (to Y.O. and S.F.), the Takeda Science Foundation (to Y.O. and S.F.), the Naito Foundation (to Y.O.), the Uehara Memorial Foundation (to S.F.), NIH R21 (grant no. AR078400 to A.A.) and Regenerative Medicine Minnesota (grant no. 092319 TR010 to A.A.). T.Ma., H.N. and N.H. were funded by a JSPS Research Fellowship. Funding Information: We thank R. Fujita, S. Ogawa, Y. Tsuchiya, K. Yoshioka, Y. Kitajima, D. T. Shima, Y. Kubota and N. Suzuki for sharing materials and technical assistance. We also thank S. Burden for providing Mlc1f-Cre mice; I. Imayoshi and R. Kageyama for providing Hes1-flox mice and T. Honjo for providing RBPJ-flox mice. The Pax7 and MF20 antibodies, developed by A. Kawakami and D.A. Fischman, respectively, were obtained from the Developmental Studies Hybridoma Bank developed under the auspices of the NICHD and maintained by the University of Iowa. This work was supported by the FOREST program of the Japan Science and Technology Agency (JST, grant no. JPMJFR205C to Y.O.), the Japan Agency for Medical Research and Development (AMED, grant no. JP19bm0704036 to Y.O.) and Grants-in-Aid for Scientific Research KAKENHI (grant nos. 25882024 to S.M.; 15H05368, 18H03193 and 20K21763 to Y.O.; 20K19641 to S.F. and 20J01669 to T.Ma.). This work was also supported, in part, by the Center for Metabolic Regulation of Healthy Aging (to Y.O. and S.F.), the Takeda Science Foundation (to Y.O. and S.F.), the Naito Foundation (to Y.O.), the Uehara Memorial Foundation (to S.F.), NIH R21 (grant no. AR078400 to A.A.) and Regenerative Medicine Minnesota (grant no. 092319 TR010 to A.A.). T.Ma., H.N. and N.H. were funded by a JSPS Research Fellowship. Publisher Copyright: {\textcopyright} 2022, The Author(s), under exclusive licence to Springer Nature Limited.",

year = "2022",

month = feb,

doi = "10.1038/s42255-022-00533-9",

language = "English (US)",

volume = "4",

pages = "180--189",

journal = "Nature Metabolism",

issn = "2522-5812",

publisher = "Nature Research",

number = "2",

}

TY - JOUR

T1 - The endothelial Dll4–muscular Notch2 axis regulates skeletal muscle mass

AU - Fujimaki, Shin

AU - Matsumoto, Tomohiro

AU - Muramatsu, Masashi

AU - Nagahisa, Hiroshi

AU - Horii, Naoki

AU - Seko, Daiki

AU - Masuda, Shinya

AU - Wang, Xuerui

AU - Asakura, Yoko

AU - Takahashi, Yukie

AU - Miyamoto, Yuta

AU - Usuki, Shingo

AU - Yasunaga, Kei ichiro

AU - Kamei, Yasutomi

AU - Nishinakamura, Ryuichi

AU - Minami, Takashi

AU - Fukuda, Takaichi

AU - Asakura, Atsushi

AU - Ono, Yusuke

N1 - Funding Information: We thank R. Fujita, S. Ogawa, Y. Tsuchiya, K. Yoshioka, Y. Kitajima, D. T. Shima, Y. Kubota and N. Suzuki for sharing materials and technical assistance. We also thank S. Burden for providing Mlc1f-Cre mice; I. Imayoshi and R. Kageyama for providing Hes1-flox mice and T. Honjo for providing RBPJ-flox mice. The Pax7 and MF20 antibodies, developed by A. Kawakami and D.A. Fischman, respectively, were obtained from the Developmental Studies Hybridoma Bank developed under the auspices of the NICHD and maintained by the University of Iowa. This work was supported by the FOREST program of the Japan Science and Technology Agency (JST, grant no. JPMJFR205C to Y.O.), the Japan Agency for Medical Research and Development (AMED, grant no. JP19bm0704036 to Y.O.) and Grants-in-Aid for Scientific Research KAKENHI (grant nos. 25882024 to S.M.; 15H05368, 18H03193 and 20K21763 to Y.O.; 20K19641 to S.F. and 20J01669 to T.Ma.). This work was also supported, in part, by the Center for Metabolic Regulation of Healthy Aging (to Y.O. and S.F.), the Takeda Science Foundation (to Y.O. and S.F.), the Naito Foundation (to Y.O.), the Uehara Memorial Foundation (to S.F.), NIH R21 (grant no. AR078400 to A.A.) and Regenerative Medicine Minnesota (grant no. 092319 TR010 to A.A.). T.Ma., H.N. and N.H. were funded by a JSPS Research Fellowship. Funding Information: We thank R. Fujita, S. Ogawa, Y. Tsuchiya, K. Yoshioka, Y. Kitajima, D. T. Shima, Y. Kubota and N. Suzuki for sharing materials and technical assistance. We also thank S. Burden for providing Mlc1f-Cre mice; I. Imayoshi and R. Kageyama for providing Hes1-flox mice and T. Honjo for providing RBPJ-flox mice. The Pax7 and MF20 antibodies, developed by A. Kawakami and D.A. Fischman, respectively, were obtained from the Developmental Studies Hybridoma Bank developed under the auspices of the NICHD and maintained by the University of Iowa. This work was supported by the FOREST program of the Japan Science and Technology Agency (JST, grant no. JPMJFR205C to Y.O.), the Japan Agency for Medical Research and Development (AMED, grant no. JP19bm0704036 to Y.O.) and Grants-in-Aid for Scientific Research KAKENHI (grant nos. 25882024 to S.M.; 15H05368, 18H03193 and 20K21763 to Y.O.; 20K19641 to S.F. and 20J01669 to T.Ma.). This work was also supported, in part, by the Center for Metabolic Regulation of Healthy Aging (to Y.O. and S.F.), the Takeda Science Foundation (to Y.O. and S.F.), the Naito Foundation (to Y.O.), the Uehara Memorial Foundation (to S.F.), NIH R21 (grant no. AR078400 to A.A.) and Regenerative Medicine Minnesota (grant no. 092319 TR010 to A.A.). T.Ma., H.N. and N.H. were funded by a JSPS Research Fellowship. Publisher Copyright: © 2022, The Author(s), under exclusive licence to Springer Nature Limited.

PY - 2022/2

Y1 - 2022/2

N2 - Adult skeletal muscle is a highly plastic tissue that readily reduces or gains its mass in response to mechanical and metabolic stimulation; however, the upstream mechanisms that control muscle mass remain unclear. Notch signalling is highly conserved, and regulates many cellular events, including proliferation and differentiation of various types of tissue stem cell via cell–cell contact. Here we reveal that multinucleated myofibres express Notch2, which plays a crucial role in disuse- or diabetes-induced muscle atrophy. Mechanistically, in both atrophic conditions, the microvascular endothelium upregulates and releases the Notch ligand, Dll4, which then activates muscular Notch2 without direct cell–cell contact. Inhibition of the Dll4–Notch2 axis substantively prevents these muscle atrophy and promotes mechanical overloading-induced muscle hypertrophy in mice. Our results illuminate a tissue-specific function of the endothelium in controlling tissue plasticity and highlight the endothelial Dll4–muscular Notch2 axis as a central upstream mechanism that regulates catabolic signals from mechanical and metabolic stimulation, providing a therapeutic target for muscle-wasting diseases.

AB - Adult skeletal muscle is a highly plastic tissue that readily reduces or gains its mass in response to mechanical and metabolic stimulation; however, the upstream mechanisms that control muscle mass remain unclear. Notch signalling is highly conserved, and regulates many cellular events, including proliferation and differentiation of various types of tissue stem cell via cell–cell contact. Here we reveal that multinucleated myofibres express Notch2, which plays a crucial role in disuse- or diabetes-induced muscle atrophy. Mechanistically, in both atrophic conditions, the microvascular endothelium upregulates and releases the Notch ligand, Dll4, which then activates muscular Notch2 without direct cell–cell contact. Inhibition of the Dll4–Notch2 axis substantively prevents these muscle atrophy and promotes mechanical overloading-induced muscle hypertrophy in mice. Our results illuminate a tissue-specific function of the endothelium in controlling tissue plasticity and highlight the endothelial Dll4–muscular Notch2 axis as a central upstream mechanism that regulates catabolic signals from mechanical and metabolic stimulation, providing a therapeutic target for muscle-wasting diseases.

UR - https://www.scopus.com/pages/publications/85125585127

UR - https://www.scopus.com/pages/publications/85125585127#tab=citedBy

U2 - 10.1038/s42255-022-00533-9

DO - 10.1038/s42255-022-00533-9

M3 - Article

C2 - 35228746

AN - SCOPUS:85125585127

SN - 2522-5812

VL - 4

SP - 180

EP - 189

JO - Nature Metabolism

JF - Nature Metabolism

IS - 2

ER -

The endothelial Dll4–muscular Notch2 axis regulates skeletal muscle mass

Abstract

Bibliographical note

UN SDGs

Publisher link

Find It

Other files and links

Fingerprint

Cite this